DeepLook Medical, a New Haven, CT-based visual enhancement technology company for medical application, raised an undisclosed amount in Series A funding.
The round was led by Xcellerant Ventures and supported by OKG Capital.
The company intends to use the funds to leverage the capital to continue to commercialize the technology with existing and new commercial partners, expand the technology into other modalities, and extend its reach globally.
Led by CEO Marissa Fayer, DeepLook Medical focuses on visual enhancement technology to advance medical imaging. DL Precise™ is the first in a series of products using the its shape-recognition software to delineate the details of tumor morphology, and to better diagnosis and treatment of malignancy across the field of oncology. The company is leveraging other complementary AI advances to further enhance its patented technology.
